EUVIMEDEUVIMED entdecken
Multizentrische Studie

Amantadine use in the French prospective NS-Park cohort

Margherita Fabbri iD, Vanessa Rousseau, Jean-Christophe Corvol, Agnès Sommet, Florence Tubach, Yann De Rycke, Nathalie Bertille, Yajiththa Selvarasa, Stephanie Carvalho, Véronique Chaigneau, Christine Brefel-Courbon, Fabienne Ory-Magne und 25 weitere

Journal of Neural Transmission · 2024

DOI: 10.1007/s00702-024-02772-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neural Transmission, 2024. Verfasst von Margherita Fabbri und 36 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC1436, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Ce…. Hauptthemen laut MEDLINE: Amantadine, Antiparkinson Agents, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmantadineAntiparkinson AgentsParkinson DiseaseHumansMaleFemaleFranceAgedMiddle AgedProspective StudiesDyskinesia, Drug-InducedCross-Sectional StudiesLevodopaLongitudinal StudiesCohort Studies

Stichwörter der Autor:innen

AmantadineMotor complicationsNS-ParkParkinson’s disease

Substanzen

AmantadineAntiparkinson AgentsLevodopa

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC1436, Toulouse Parkinson Expert Centre, Toulouse NeuroToul Center of Excellence in Neurodegeneration (COEN), University of Toulouse…
  • Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire-Faculté de Médecine, Toulouse, France. margheritafabbrimd@gmail.com.
  • French NS-PARK/F-CRIN Network, Clermont-Ferrand, France. margheritafabbrimd@gmail.com.
  • Department of Clinical Pharmacology, Clinical Investigation Center CIC1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • French NS-PARK/F-CRIN Network, Clermont-Ferrand, France.
  • Sorbonne Université, Institut du Cerveau, Paris Brain Institute, ICM, Inserm, CNRS, Paris, France.

ORCID-Profile: Margherita Fabbri

Zitieren

APA

Fabbri, M., Rousseau, V., Corvol, J. C., Sommet, A., Tubach, F., De Rycke, Y., Bertille, N., Selvarasa, Y., Carvalho, S., Chaigneau, V., Brefel-Courbon, C., Ory-Magne, F., Tessier, S., Tir, M., Bereau, M., Meissner, W. G., Thiriez, C., Marques, A., Remy, P., …, & French N. S.-Park network (2024). Amantadine use in the French prospective NS-Park cohort. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02772-4

Vancouver

Fabbri M, Rousseau V, Corvol JC, Sommet A, Tubach F, De Rycke Y, et al. Amantadine use in the French prospective NS-Park cohort. Journal of Neural Transmission. 2024. doi:10.1007/s00702-024-02772-4

BibTeX
@article{Fabbri2024,
  author = {Fabbri, Margherita and Rousseau, Vanessa and Corvol, Jean-Christophe and Sommet, Agnès and Tubach, Florence and De Rycke, Yann and Bertille, Nathalie and Selvarasa, Yajiththa and Carvalho, Stephanie and Chaigneau, Véronique and Brefel-Courbon, Christine and Ory-Magne, Fabienne and Tessier, Samuel and Tir, Melissa and Bereau, Matthieu and Meissner, Wassilios G and Thiriez, Claire and Marques, Ana and Remy, Philippe and Schneider, Vincent and Moro, Elena and Defebvre, Luc and Houeto, Jean Luc and Prange, Stephane and Eusebio, Alexandre and Geny, Christian and Frismand, Solène and Damier, Philippe and Reuther, Caroline Giordana and Castelnovo, Giovanni and Benatru, Isabelle and De Maindreville, Anne Doe and Drapier, Sophie and Maltête, David and Lagha-Boukbiza, Ouhaid and Rascol, Olivier and French N. S.-Park network, French N. S.-Park network},
  title = {Amantadine use in the French prospective NS-Park cohort},
  journal = {Journal of Neural Transmission},
  year = {2024},
  doi = {10.1007/s00702-024-02772-4}
}
Kostenlos starten →